The U.K. had signaled it would move swiftly in approving a vaccine to protect its population, and doctors across the country were put on standby for a possible rollout
Mexico's government is due to sign a contract with pharmaceutical company Pfizer for the delivery of its coronavirus vaccine, Deputy Health Minister Hugo Lopez-Gatell said
The application to the European Medicines Agency (EMA) comes after the companies applied for US approval on Nov. 20, taking them a step closer to launching their vaccine.
United Airlines Holdings Inc. has begun flights to ready Pfizer's vaccine for distribution if it receives regulatory approval, said a person familiar with the matter
The U.K. had long signaled it would move fast on any promising vaccine candidate
Students aspiring to study abroad may face tougher competition in 2021, AstraZeneca's manufacturing error casts doubt over its potential, and other news relevant to India's fight against the pandemic
Many Asian countries are not betting on it partly due to tropical heat, remote island communities and a lack of ultra-cold freezers
Covid may impact vision of some patients, ethical dilemma of denying vaccine to trial participants, UP artisans start selling online-news relevant to India's fight against the pandemic
If regulators approve any of the vaccines in coming weeks, the distribution could begin almost immediately
BioNTech is also working with U.S. pharma giant Pfizer on the vaccine
Clarification comes after a Mumbai-based tour operator announces 'vaccine tourism', solicits customer interest
An intellectual property regime that is not flexible enough to manage the coronavirus crisis is one that will break under the weight of that techno-dystopia.
The nation with the world's second-highest infections plans to use the existing cold chain network in place for its Universal Immunization Program
The UK is expected to receive a total of 40 million doses by the end of 2021, enough to vaccinate up to a third of the population, with the majority of doses anticipated in the first half of next year
Pfizer and Moderna may have an initial advantage in dealing with manufacturing challenges, as their novel messenger RNA technology can be scaled up.
Britain formally asked its medical regulator, the MHRA, last week to assess the suitability of the Pfizer-BioNTech vaccine
The price per dose of the Russian coronavirus vaccine Sputnik V will be much lower than that of the vaccines of US drug giants Pfizer and Moderna, said the Russian vaccine's official Twitter account
The Astra vaccine costs a fraction of the price set by Pfizer; it should be easier to deploy far and wide than other shots.
Pfizer asked US regulators to allow emergency use of its COVID vaccine, starting clock on a process that could bring limited first shots as early as next month and eventually an end to the pandemic
The action comes days after Pfizer Inc and its German partner BioNTech announced that its vaccine appears 95% effective at preventing Covid-19